Study of anti-platelet drugs in artery disease
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at how anti-platelet medicines like aspirin and clopidogrel work in people with hardened arteries (atherosclerosis) or peripheral artery disease (PAD). The goal is to understand how these drugs affect your body's clotting system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have either atherosclerosis (hardening of the arteries) or peripheral artery disease (PAD) diagnosed by your doctor
- You cannot have diabetes
- You must not have taken any anti-platelet drugs (like aspirin or clopidogrel) or blood thinners (like warfarin) in the last 2 weeks
- You must be willing to avoid certain medicines like ibuprofen, antihistamines, or some antidepressants for 5 days before and during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a prevention program for people who have already had a heart event, stroke, or leg artery blockage. It is designed to help reduce the risk of future heart problems.
This study compares two blood-thinning medications—aspirin and clopidogrel—in people with chronic coronary artery disease (narrowed heart arteries). Researchers want to learn which medication works better at preventing heart problems over 5 years.
This trial tests whether clopidogrel (a blood-thinning medicine) can prevent future heart attacks or strokes in people who have early, “subclinical” plaque in their heart arteries. You may be considered if scans show plaque but not major artery blockage that needs a procedure.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This study looks at how blood platelets work in people who have high levels of lipoprotein(a), a type of fat in the blood that can increase heart risk. It tests if common blood thinners (aspirin and clopidogrel) work differently in these patients.
This study follows people with known coronary artery disease to understand how long-term “blood thinner” treatments are used and how they affect health over time. You may be asked to share medical information and come in for follow-up to help researchers compare outcomes.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.